» Authors » Nevenka Dimitrova

Nevenka Dimitrova

Explore the profile of Nevenka Dimitrova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 1257
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang W, Yin C, Lento P, Adem P, Dimitrova N, Fallon J
Circ Genom Precis Med . 2024 Jun; 17(4):e004487. PMID: 38910558
Background: Inflammatory heart disease can be triggered by a variety of causes, both infectious and noninfectious in nature. We hypothesized that inflammatory cardiomyopathy is potentially related to microbial infection. Methods:...
2.
Tsanov K, Barriga F, Ho Y, Alonso-Curbelo D, Livshits G, Koche R, et al.
bioRxiv . 2024 Apr; PMID: 38562717
Driver gene mutations can increase the metastatic potential of the primary tumor, but their role in sustaining tumor growth at metastatic sites is poorly understood. A paradigm of such mutations...
3.
Gilles A, Hu L, Virdis F, SantAngelo D, Dimitrova N, Hedrick J, et al.
J Immunol . 2023 Oct; 211(11):1630-1642. PMID: 37811896
Peptide loading of MHC class II (MHCII) molecules is facilitated by HLA-DM (DM), which catalyzes CLIP release, stabilizes empty MHCII, and edits the MHCII-bound peptide repertoire. HLA-DO (DO) binds to...
4.
Tang K, Amenabar J, Schussel J, Torres-Pereira C, Bonfim C, Dimitrova N, et al.
Odontology . 2023 Jul; 112(1):299-308. PMID: 37458838
The overarching goal of this study is to predict the risk of developing oral squamous cell carcinoma (OSCC) in Fanconi anemia (FA) patients. We have compared the microRNA (miRNA, miR)...
5.
Banavar G, Ogundijo O, Julian C, Toma R, Camacho F, Torres P, et al.
Oral Oncol . 2023 Jul; 145:106480. PMID: 37454545
Objective: Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) can go undetected resulting in late detection and poor outcomes. We describe the development and validation of CancerDetect...
6.
Baslan T, Morris 4th J, Zhao Z, Reyes J, Ho Y, Tsanov K, et al.
Nature . 2022 Aug; 608(7924):795-802. PMID: 35978189
Although p53 inactivation promotes genomic instability and presents a route to malignancy for more than half of all human cancers, the patterns through which heterogenous TP53 (encoding human p53) mutant...
7.
Banavar G, Ogundijo O, Toma R, Rajagopal S, Lim Y, Tang K, et al.
NPJ Genom Med . 2021 Dec; 6(1):105. PMID: 34880265
Despite advances in cancer treatment, the 5-year mortality rate for oral cancers (OC) is 40%, mainly due to the lack of early diagnostics. To advance early diagnostics for high-risk and...
8.
Baslan T, Kendall J, Volyanskyy K, McNamara K, Cox H, DItalia S, et al.
Elife . 2020 May; 9. PMID: 32401198
Copy number alterations (CNAs) play an important role in molding the genomes of breast cancers and have been shown to be clinically useful for prognostic and therapeutic purposes. However, our...
9.
Petzke M, Volyanskyy K, Mao Y, Arevalo B, Zohn R, Quituisaca J, et al.
mBio . 2020 Mar; 11(2). PMID: 32184234
A bioinformatics approach was employed to identify transcriptome alterations in the peripheral blood mononuclear cells of well-characterized human subjects who were diagnosed with early disseminated Lyme disease (LD) based on...
10.
Huang W, Hamouche J, Wang G, Smith M, Yin C, Dhand A, et al.
Int J Mol Sci . 2020 Feb; 21(3). PMID: 32033143
Multidrug-resistant (MDR) is one of the main causes of morbidity and mortality in hospitalized patients and the leading cause of nosocomial infections. We investigated, here, two MDR clinical isolates from...